Monitoring invitro antibacterial efficacy of Terminalia alata Heyne ex.Roth, against MDR enteropathogenic bacteria isolated from clinical samples

Journal of Acute Medicine

Volumn 3, Issue 3, 2013, Pages 93-102

  Rath, Shakti ^a   Padhy, Rabindra N ^a  

^a SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY   (India)

Author keywords

Antibacterial activity; Enteropathogenic bacteria; Minimum bactericidal concentration; Minimum inhibitory concentration; Phytochemical analysis; Terminalia alata

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONE; ALCOHOL; ALKALOID; ANTIINFECTIVE AGENT; CARBOHYDRATE; CHLOROFORM; FLAVONOID; HEXANE; METHANOL; PETROLEUM ETHER; PLANT EXTRACT; TANNIN DERIVATIVE; TERMINALIA ALATA EXTRACT; UNCLASSIFIED DRUG; WATER;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BARK; BROTH DILUTION; CONTROLLED STUDY; DISK DIFFUSION; ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA AEROGENES; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF; PRIORITY JOURNAL; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SHIGELLA; SHIGELLA DYSENTERIAE; SHIGELLA SONNEI; TERMINALIA; TERMINALIA ALATA; VIBRIO CHOLERAE;

EID: 84886429057     PISSN: 22115587     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacme.2013.06.002     Document Type: Article

References (65)

1. Rahman M.A., Begum K., Rashid M.E., Rashid M.H. Medicinal plant diversity in the flora of Bangladesh and their conservation: 2. A report on ten angiosperm families. Plant Arch 2012, 12:1023-1035.
2. Srivastava A., Patel S.P., Mishra R.K., Vasishtha R.K., Singh A., Puskar A.K. Ethnomedicinal importance of plants of Amarkantak region, Madhya Pradesh, India. Int J Med Arom Plant 2012, 2:53-59.
3. Rath S., Padhy R.N. Surveillance of multidrug resistance of 10 enteropathogens in a teaching hospital and invitro efficacy of 25 ethnomedicinal plants used by an Indian aborigine. Asian Pacif J Trop Dis 2012, 2:S336-S346.
4. Hawk C., Ndetan H., Evans M.W. Potential role of complementary and alternative health care providers in chronic disease prevention and health promotion: an analysis of national health interview survey data. Prev Med 2012, 54:18-22.
5. Global atlas of traditional, complementary and alternative medicine 2005, WHO, World Health Organization, Geneva.
6. Frenkel M., Arye E.B., Carlson C., Sierpina V. Integrating complementary and alternative medicine into conventional primary care: the patient perspective. Explore 2008, 4:178-186.
7. George M., Topaz M. A systematic review of complementary and alternative medicine for asthma self-management. Nurs Clin North Am 2013, 48:53-149.
8. Saquib J., Parker B.A., Natarajan L., et al. Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer. Complement Ther Med 2012, 20:283-290.
9. WHO traditional medicine strategy 2011 2011, 1-14. WHO, WHO/EMP/MIE/2011.2.3, World Health Organization, Geneva, Available at, Accessed 15.01.13. http://apps.who.int/medicinedocs/documents.
10. Dubey D., Rath S., Sahu M.C., Debata N.K., Padhy R.N. Antimicrobials of plant origin against multi-drug resistant bacteria including the TB bacterium and economics of plant-drugs-Introspection. Indian J Trad Knowl 2012, 11:225-233.
11. Saini N., Saini K., Singh G.K. Establishment of an herbal industry in India. Int J Pharm Bio Archs 2011, 2:1011-1019.
12. Ramya S., Kalaivani T., Rajasekaran C., et al. Antimicrobial activity of aqueous extracts of bark, root, leaves and fruits of Terminalia arjuna Wight & Arn. Ethnobot Leaflet 2008, 12:1192-1197.
13. Sen S., Chakraborty R., De B. Challenges and opportunities in the advancement of herbal medicine: India's position and role in a global context. J Herb Med 2011, 1:67-75.
14. Traditional and Alternative Medicines, Research and Policy Perspectives 2009, Daya Publishing House, New Delhi. T. De Silva, T. Bahorum, M. Sahu, L.M. Huong (Eds.).
15. Jothy S.L., Zakaria Z., Chen Y., Lau Y.L., Latha L.Y., Sasidharan S. Acute oral toxicity of methanolic seed extract of Cassia fistula in mice. Molecules 2011, 16:5268-5282.
16. Sahu M.C., Dubey D., Rath S., Debata N.K., Padhy R.N. Multidrug resistance of Pseudomonas aeruginosa as known from surveillance of nosocomial and community infections in an Indian teaching hospital. J Publ Health 2012, 20:413-423.
17. Emmerson A.M., Enstone J.E., Griffin M., Kelsey M.C., Smyth E.T. The second national prevalence survey of infection in hospitals-overview of results. J Hosp Infect 1996, 32:175-190.
18. Pelezar M.J., Chan E.C., Krieg N.R. Microbiology 1993, McGraw-Hill, New York.
19. Olson M.M., Lee J.T. Continuous, 10-year wound infection surveillance. Results, advantages, and unanswered questions. Arch Surg 1990, 125:794-803.
20. Anonymous Nosocomial infection rates for inter hospital comparison: limitations and possible solutions. A report from the national nosocomial infections surveillance (NNIS) system. Infect Control Hosp Epidemiol 1991, 12:609-621.
21. Dubey D., Rath S., Sahu M.C., Debata N.K., Padhy R.N. Status of multidrug resistance in tubercle bacillus and phytochemicals for the control. J Publ Health 2013, 21:115-119.
22. Dubey D., Rath S., Sahu M.C., Patnaik L., Debata N.K., Padhy R.N. Surveillance of infection status of drug resistant Staphylococcus aureus in an Indian teaching hospital. Asian Pacif J Trop Dis 2013, 3:133-142.
23. Falagas M.E., Rafailidis P.I., Matthaiou D.K., Virtzili S., Nikita D., Michalopoulos A. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int J Antimicrob Agents 2008, 32:450-454.
24. Rath S., Dubey D., Sahu M.C., Debata N.K., Padhy R.N. Surveillance of multidrug resistant Escherichia coli in community and a hospital from Odisha. Asian Pacif J Trop Dis 2013, D141. in press.
25. Ahmad I., Aqil F. Invitro efficacy of bioactive extracts of 15 medicinal plants against ESβL-producing multidrug-resistant enteric bacteria. Microbiol Res 2007, 162:264-275.
26. Rath S., Dubey D., Sahu M.C., Debata N.K., Padhy R.N. Antibacterial activity of 25 medicinal plants used by aborigines of India against six uropathogens with surveillance of multidrug resistance. Asian Pacif J Trop Biomed 2012, 2:S846-S854.
27. Sahu M.C., Debata N.K., Padhy R.N. Antibacterial activity of Argemone mexicana L. against multi-drug resistant Pseudomonas aeruginosa. Asian Pacif J Trop Biomed 2012, 2:S800-S807.
28. Dubey D., Padhy R.N. Antibacterial activity of Lantana camara L. against multidrug resistant pathogens from ICU patients of a teaching hospital. J Herb Med 2013, 3:65-75.
29. Dubey D., Rath S., Sahu M.C., Paty B.P., Debata N.K., Padhy R.N. Antibacterial activity of medicinal plants used by aborigines of Kalahandi, Orissa, India against multidrug resistant bacteria. Asian Pacif J Trop Biomed 2012, 2:S846-S854.
30. Rath S., Padhy R.N. Monitoring invitro efficacy of Holarrhena antidysenterica against eight multidrug resistant enteropathogenic bacteria. Asian Pacif J Trop Dis 2013, D151. in press.
31. Bauer A.M., Kirby W.M.M., Sherris J.C., Turk M. Antibiotic susceptibility testing using standard single disc method. Am J Clin Pathol 1966, 45:493-496.
32. Performance Standard For Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement 2011, Clinical and Laboratory Standards Institute, Document M200-S21, CLSI, Wayne.
33. Multidrug Resistance: A Global Concern 2012, Bentham Publishers, Sharjah. 10.2174/97816080529291120101. A.U. Khan, Z. Raffaele (Eds.).
34. Luksamijarulkul P., Parikumsil N., Poomsuwan V., Konkeaw W. Nosocomial surgical site infection among Photharam hospital patients with surgery: incidence, risk factors and development of risk screening form. J Med Assoc Thai 2006, 89:81-89.
35. Foster SD. The economic burden of antibiotic resistance - evidence from three recent studies. 2010 annual conference on antimicrobial resistance, Bethesda, 1-3 Feb. 2010.
36. Anonymous. Prevention and containment of antimicrobial resistance. WHO South-East Asia: Report of a regional meeting, Chiang Mai, Thailand, 8 June-11 June 2010.
37. Mulualem Y., Kasa T., Mekonnen Z., Suleman S. Occurrence of extended spectrum beta lactamases in multi-drug resistant Escherichia coli isolated from a clinical setting in Jimma University Specialized Hospital, Jimma, southwest Ethiopia. East Afr J Public Health 2012, 9:58-61.
38. Ochoa T.J., Ecker L., Barletta F., et al. Age-related susceptibility to infection with diarrheagenic Escherichia coli among infants from Periurban areas in Lima, Peru. Clin Infect Dis 2009, 49:1694-1702.
39. Miyakis S., Pefanis A., Tsakris A. The challenges of antimicrobial drug resistance in Greece. Clin Infect Dis 2011, 53:177-184.
40. Das A., Manickam P., Hutin Y., et al. An outbreak of cholera associated with an unprotected well in Parbatia, Orissa, Eastern India. J Health Popul Nutr 2009, 27:646-651.
41. Vaishnavi C., Singh M. Preliminary investigation of environmental prevalence of Clostridium difficile affecting inpatients in a north Indian hospital. Indian J Med Microbiol 2012, 30:89-92.
42. Hoelzer K., Moreno Switt A.I., Wiedmann M. Animal contact as a source of human non-typhoidal salmonellosis. Vet Res 2011, 42:34.
43. Rowan N.J. Defining established and emerging microbial risks in the aquatic environment: current knowledge, implications and outlooks. Int J Microbiol 2011, 2011:462832.
44. Schwaber M., Klarfeld-Lidji S., Navon-Venezia S., Schwartz D., Leavitt A., Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008, 52:1028-1033.
45. Haque A., Haque A., Sarwar Y., et al. Identification of drug resistance genes in clinical isolates of Salmonella typhi for development of diagnostic multiplex PCR. Pak J Med Sci 2005, 21:402-407.
46. Shrestha C.D., Malla S., Maharjan L. Multidrug resistant Shigella species in Nepal, a retrospective study conducted at National Public Health Laboratory (NPHL), 1999 to 2002. J Nepal Health Res Counc 2002, 4:51-59.
47. Das S., Choudhry S., Saha R., Ramachandran V.G., Kaur K., Sarkar B.L. Emergence of multiple drug resistance of Vibrio cholerae O1 in East Delhi. J Infect Dev Ctries 2011, 5:294-298.
48. Davin-Régli A., Bolla J.M., James C.E., et al. Membrane permeability and regulation of drug 'influx and efflux' in enterobacterial pathogens. Curr Drug Targets 2008, 9:750-759.
49. Mamelli L., Petit S., Chevalier J., et al. New antibiotic molecules: bypassing the membrane barrier of Gram negative bacteria increases the activity of peptide deformylase inhibitors. PLoS One 2009, 4:e6443.
50. Pagès J.M., James C.E., Winterhalter M. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol. 2008, 6:893-903.
51. Warnes S.L., Highmore C.J., William Keevil C.W. Horizontal transfer of antibiotic resistance genes on abiotic touch surfaces: implications for public health. MBio 2012, 3. 10.1128/mBio.00489-12.
52. McMurry L.M., Levy S.B. The periplasmic protein mppA is not involved in regulation of marA in Escherichia coli. Antimicrob Agents Chemother 2011, 55:4939-4942.
53. Leekha S., Terrell C.L., Edson R.S. General principles of antimicrobial therapy. Mayo Clin Proc 2011, 86:156-167.
54. Menrath A., Wieler L.H., Heidemanns K., Semmler T., Fruth A., Kemper N. Shiga toxin producing Escherichia coli: identification of non-O157:H7-super-shedding cows and related risk factors. Gut Pathogen 2010, 2:7-15.
55. Rice L.B. Mechanisms of resistance and clinical relevance of resistance to beta-lactams, glycopeptides, and fluoroquinolones. Mayo Clin Proc 2012, 87:198-208.
56. Sun P.P., Perianayagam M.C., Jaber B.L. Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanism. Kidney Int 2009, 76:S20-S25.
57. Sekirov I., Russell S.L., Antunes L.C.M., Finlay B.B. Gut microbiota in health and disease. Physiol Rev 2010, 90:859-904.
58. Sachdeva P., Misra R., Tyagi A.K., Singh Y. The sigma-factors of Mycobacterium tuberculosis: regulation of the regulators. FEBSJ 2010, 277:605-626.
59. Bergval I., Kwok B., Schuitema A., Kremer K., van Soolingen D., et al. Pre-existing isoniazide resistance, but not the genotype of Mycobacterium tuberculosis drives rifampicin resistance codon preference invitro. Plos One 2012, 7:e29108.
60. Dubey D., Rath S., Sahu M.C., Rout S., Debata N.K., Padhy R.N. A report on infection dynamics of inducible clindamycin resistance among Staphylococcus aureus isolates from a teaching hospital in India. Asian Pacif J Trop Biomed 2013, 3:148-153.
61. Kar A., Borthakur S.K. Medicinal plants used against dysentery, diarrhoea, and cholera by tribes of Kameng district of Arunachal Pradesh. Nat Prod Radian 2008, 7:176-181.
62. Shanmugam S., Annadurai M., Rajendran K. Ethnomedicinal plants used to cure diarrhoea and dysentery in Pachalur hills of Dindigul district in Tamil Nadu, Southern India. J Appl Pharmac Sci 2011, 1:94-97.
63. Sinha R., Lakra V. Edible weeds of tribals of Jharkhand, Orissa and West Bengal. Ind J Trad Knowl 2007, 6:217-222.
64. Fung M., Simpson S., Packer C. Identification of innovation in public health. J Publ Health 2011, 33:123-130.
65. Constable S., Ham A., Pirmohamed M. Herbal medicines and acute medical emergency admissions to hospital. Br J Clin Pharmacol 2006, 63:2247-2248.